Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Proteomics International Laboratories Ltd

PIQ.AX ✗ NOT COMPLIANT ☆ Track — members

ASX · Healthcare · Biotechnology & Medical Research ·

Australia Micro Cap Analyst: N/A

Last Close

$0.12

▼ -1.52%

Market Cap $18.96M · Vol 65.67K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$18.96M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

51.43

Momentum

Beta

0.00

vs Market

52W High

$0.61

79.97% below

52W Low

$0.07

70.24% above

Volume

65.67K

Avg 369.96K

P/B

4.04

Price-to-book

ROE

N/A

Return on equity

Free Float

73.31%

Public shares

Shariah Compliance8 STANDARDS

✗ Proteomics International Laboratories Ltd (PIQ.AX) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PIQ.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.84%

-16.67%

+8.33%

-58.86%

YTD

-75.19%

-53.57%

-75.41%

-85.68%

Financials & Valuation

TTM · Annual

Total Revenue	$2.18M
Net Income	$-5,365,650.00
Revenue Growth (YoY)	-12.83%
Gross Margin	100.00%
Operating Margin	-249.57%
Net Profit Margin	-246.18%
ROE	N/A
ROA · ROIC	-63.57% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	13.17
P/B	4.04
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	165.37M

Technical Indicators

50-Day SMA	$0.10
200-Day SMA	$0.22
RSI (14)	51.43
Beta	0.00
52-Week High	$0.61
52-Week Low	$0.07

Volume Today	65.67K
Avg Daily Volume (30D)	369.96K
Relative Volume	0.18x
Volatility (10D)	92.34
Volatility (30D)	130.31
Free Float	73.31%

Analyst Consensus

N/A

Current Price $0.12

Mean Target N/A

52W Low$0.07 52W High$0.61

Current

Target

$0.07 $0.61

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG007HW1G62

ISINAU000000PIQ0

CountryAustralia

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Proteomics International Laboratories Ltd is an Australia-based medical technology company. The Company is engaged in predictive diagnostics and bioanalytical services. It specializes in the area of proteomics, the industrial scale study of the structure and function of proteins. It focuses on developing and commercializing diagnostic tests for chronic diseases. Its principal activities fall into three key areas: commercialization of PromarkerD, the predictive test for diabetic kidney disease (DKD) and future kidney function decline in patients with type 2 diabetes; precision diagnostic tests in development: the Promarker pipeline, and specialist accredited analytical services on a commercial basis. Its Promarker pipeline and analytical services include PromarkerEndo, PromarkerEso and OxiDx technology. PromarkerEndo is a prototype diagnostic test for endometriosis identifying up to 90% of patients with the disease. PromarkerEso is a prototype diagnostic test for esophageal cancer.